Bains Rochaknaveen, Peracha Hamna Talha, Chandrasekaran Sai Harini, Sneha Reddy Kambam, Kumar Divyanshi Vijay, Prakash Ananya, Singh Manjeet, Khan Misbah Kamal, Rath Shree
Psychiatry, St. Francis Emory Healthcare, Columbus, USA.
Internal Medicine, Fatima Jinnah Medical University, Lahore, PAK.
Cureus. 2025 May 27;17(5):e84885. doi: 10.7759/cureus.84885. eCollection 2025 May.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by cognitive deterioration and behavioral symptoms, significantly impacting patients and caregivers. Behavioral and psychological symptoms of dementia (BPSD), including agitation, depression, and apathy, are common in AD and complicate its management. Conventional treatments, such as cholinesterase inhibitors and antipsychotics, offer limited benefits and often carry adverse effects. Repetitive transcranial magnetic stimulation (rTMS), a non-invasive neuromodulatory technique, has emerged as a promising alternative by modulating cortical excitability and promoting neuroplasticity. This narrative review aims to evaluate the current literature on the therapeutic effects of rTMS in AD, with a focus on its impact on cognitive function and behavioral symptoms. A comprehensive literature search was conducted across PubMed, MEDLINE, PsycINFO, Embase, and the Cochrane Library. Studies were selected based on predefined inclusion and exclusion criteria, with quality assessed using the Cochrane Risk of Bias Tool and the Newcastle-Ottawa Scale. Findings indicate that high-frequency rTMS can improve memory, language, and executive functions, while also reducing neuropsychiatric symptoms such as agitation and depression. Mechanistically, rTMS appears to influence cortical plasticity, neurotransmitter regulation, and neurotrophic factor expression. Despite these encouraging outcomes, heterogeneity in study design, stimulation protocols, and patient populations limit generalizability. Further research through large-scale, standardized, multicentric trials is necessary to confirm its efficacy and define optimal therapeutic parameters. In conclusion, rTMS holds promise as an adjunctive intervention in AD, potentially improving cognitive and behavioral outcomes while offering a favorable safety profile.
阿尔茨海默病(AD)是一种进行性神经退行性疾病,其特征为认知功能衰退和行为症状,对患者及其照料者产生重大影响。痴呆的行为和心理症状(BPSD),包括激越、抑郁和淡漠,在AD中很常见,并且使其管理变得复杂。传统治疗方法,如胆碱酯酶抑制剂和抗精神病药物,疗效有限且常常伴有不良反应。重复经颅磁刺激(rTMS)是一种非侵入性神经调节技术,通过调节皮层兴奋性和促进神经可塑性,已成为一种有前景的替代方法。本叙述性综述旨在评估当前关于rTMS在AD治疗效果的文献,重点关注其对认知功能和行为症状的影响。在PubMed、MEDLINE、PsycINFO、Embase和Cochrane图书馆进行了全面的文献检索。根据预先定义的纳入和排除标准选择研究,使用Cochrane偏倚风险工具和纽卡斯尔-渥太华量表评估质量。研究结果表明,高频rTMS可以改善记忆、语言和执行功能,同时还能减轻激越和抑郁等神经精神症状。从机制上讲,rTMS似乎会影响皮层可塑性、神经递质调节和神经营养因子表达。尽管有这些令人鼓舞的结果,但研究设计、刺激方案和患者群体的异质性限制了其普遍性。需要通过大规模、标准化、多中心试验进行进一步研究,以证实其疗效并确定最佳治疗参数。总之,rTMS有望作为AD的辅助干预措施,可能改善认知和行为结果,同时具有良好的安全性。